The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis

BACKGROUND: Several clinical trials have evaluated the efficacy and safety of interleukin-13 (IL-13) with lebrikizumab and tralokinumab in patients with moderate to severe atopic dermatitis (AD). However, the safety and efficacy of IL-13 inhibitors as a potent biologic for AD remain elusive. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Jing, Danrong, Cheng, Jun, Chen, Xiang, Shen, Minxue, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364267/
https://www.ncbi.nlm.nih.gov/pubmed/35967348
http://dx.doi.org/10.3389/fimmu.2022.923362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364267/
https://www.ncbi.nlm.nih.gov/pubmed/35967348
http://dx.doi.org/10.3389/fimmu.2022.923362

Ejemplares similares